About Solace Biotech Limited
Data last updated:
Solace Biotech Limited is a public limited company based in Saha, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 July 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24232HR2013PLC049887. Its GSTIN is 06AATCS3925J1ZU (Haryana). The company holds 5 GST registrations, of which 3 are active.
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹30 Lakh. It is led by directors including Kamal Chawla and Raman Chawla.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 195 Sector – 2 Phase – 1 Food Park Industrial Estate, Saha, Haryana, India – 133104.
As per the financials filed for FY 2024, the company reported a revenue of ₹7.14 Cr, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹2.87 Lakh (net margin 0.4%) and EBITDA of ₹1.15 Cr (EBITDA margin 16.1%). Revenue has declined at a compounded annual rate (CAGR) of 19% over three years and 7% over five years.
The company has about 10 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Solace Biotech Limited. As per MCA filings, the company has open charges of ₹9.05 Cr and satisfied charges of ₹5.61 Cr on record. Court records list 5 cases involving the company, including 2 filed by the company and 3 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website solacebiotech.in.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressPlot No. 195 Sector – 2 Phase – 1 Food Park Industrial Estate, Saha, Haryana, India – 133104
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Solace Biotech Limited
The main business activity of Solace Biotech is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Solace Biotech Limited FY 2025 filings available
Solace Biotech Limited reported revenue of ₹7.14 Cr (down 8% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Solace Biotech Limited
Revenue has declined at a compounded annual rate (CAGR) of 7% over five years, including a 8% fall in the latest year. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Solace Biotech Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.15 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2.87 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Solace Biotech Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 16.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Solace Biotech are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Solace Biotech Limited
Solace Biotech Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Lemford Biotech Private Limited | ₹7.17 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Meerut, Uttar Pradesh, India |
| Manfriday Lifesciences Private Limited | ₹7.17 Cr (FY 2024) | •••• | •••• | 14.0% | •••• | Delhi, India |
| Everwell Pharma Private Limited | ₹7.16 Cr (FY 2024) | •••• | •••• | -7.0% | •••• | Chandigarh, India |
| Kaisha Lifesciences Private Limited | ₹7.16 Cr (FY 2025) | •••• | •••• | 2052.0% | •••• | Mumbai, Maharashtra, India |
| PRS Pharmaceuticals Private Limited | ₹7.16 Cr (FY 2019) | •••• | •••• | 40.0% | •••• | Salem, Tamil Nadu, India |
| Solace Biotech Limited this company | ₹7.14 Cr (FY 2024) | •••• | •••• | -8.0% | •••• | Saha, Haryana, India |
| Healthnovo Pharmaceutical Private Limited | ₹7.14 Cr (FY 2025) | •••• | •••• | 337.0% | •••• | Mumbai, Maharashtra, India |
| Chereso Life Sciences Private Limited | ₹7.13 Cr (FY 2024) | •••• | •••• | -22.0% | •••• | Derrabassi, Punjab, India |
| Delexcel Pharma Private Limited | ₹7.13 Cr (FY 2022) | •••• | •••• | -33.0% | •••• | Medak, Telangana, India |
| Worth Medicines India Private Limited | ₹7.12 Cr (FY 2024) | •••• | •••• | 2.0% | •••• | Himachal Pradesh, India |
| Priority Pharmaceuticals Private Limited | ₹7.12 Cr (FY 2025) | •••• | •••• | 174.0% | •••• | Jaipur, Rajasthan, India |
Peers are the five companies nearest above and the five nearest below Solace Biotech by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Solace Biotech Limited
Solace Biotech Limited is audited by Srivastava V K & Associates for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Srivastava V K & Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Solace Biotech Limited
Solace Biotech has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kamal Chawla | Director | 22 Jul 2013 | 13 Years 2 Months | Current |
| Raman Chawla | Director | 22 Jul 2013 | 13 Years 2 Months | Current |
| Rohit Gupta | Director | 24 Dec 2022 | 3 Years 9 Months | Current |
Ownership and Shareholding of Solace Biotech Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Solace Biotech Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 May 2025 | Others | ₹3.85 Cr | Open |
| 22 Dec 2022 | Others | ₹3.7 Cr | Open |
| 22 Dec 2022 | Others | ₹26.2 Lakh | Open |
| 22 Dec 2022 | Others | ₹17.5 Lakh | Open |
| 22 Dec 2022 | Others | ₹32 Lakh | Open |
Total charge records: 11 View all charges
Legal Cases of Solace Biotech Limited
Solace Biotech Limited has 5 court cases on record: 2 filed by Solace Biotech, 3 filed against it. 1 case is pending and 4 are disposed. Status as checked between 21 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 3 | 0 |
| High courts | 1 | 0 | 1 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Central, Delhi | Interim or miscellaneous application | Filed against the company by Rapross Pharmaceuticals Private Limited | Disposed |
| High Court of Punjab and Haryana | Writ petition | Filed by the company against Haryana Micro and Small Enterprises Facilitation Council | Pending |
| District court, Ambala, Haryana | Execution petition | Filed against the company by an individual | Disposed |
| District court, Ambala, Haryana | Civil suit | Filed against the company by an individual | Disposed |
| District court, Ambala, Haryana | Commercial suit | Filed by the company against an individual | Disposed |
Full case history
All 5 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Solace Biotech Limited
Solace Biotech operates one associated brand: Solace Biotech Limited. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical and Ayurvedic product manufacturing, along with franchise and third-party services in India. | solacebiotech.in |
Employees and EPFO Compliance at Solace Biotech Limited
Solace Biotech Limited has a workforce of 10 employees as of Oct 08, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Solace Biotech Limited
Solace Biotech Limited has 6 board changes on record since 2013: 3 appointments and 3 cessations. The latest: Satish Kumar ceased to be Director on 26 Dec 2022.
18 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Solace Biotech Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Solace Biotech Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Solace Biotech Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Solace Biotech Limited
Solace Biotech has 5 GST registrations: 3 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AATCS3925J1ZU | Haryana | Active | 01 Jul 2017 |
| 06AATCS3925J2ZT | Haryana | Active | 09 Jun 2020 |
| 05AATCS3925J1ZW | Uttarakhand | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Solace Biotech Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Solace Biotech Limited
Solace Biotech is an active public limited company based in Saha, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 July 2013 (13+ years old) and is registered under CIN U24232HR2013PLC049887.
Solace Biotech reported revenue of ₹7.14 Cr for FY 2024 (down 8% YoY).
Solace Biotech has 3 current directors:
- Kamal Chawla - Director
- Raman Chawla - Director
- Rohit Gupta - Director
Solace Biotech reported a net profit of ₹2.87 Lakh (net margin 0.4%) and EBITDA of ₹1.15 Cr (EBITDA margin 16.1%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Solace Biotech is -19% over three years and -7% over five years. In the latest year (FY 2024) revenue fell 8%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Solace Biotech is 06AATCS3925J1ZU, registered in Haryana. The company has 5 GST registrations in all, of which 3 are active and 2 are cancelled or inactive. Other active GSTINs include 06AATCS3925J2ZT (Haryana), 05AATCS3925J1ZW (Uttarakhand).
The CIN (Corporate Identification Number) of Solace Biotech is U24232HR2013PLC049887. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Solace Biotech has 5 court cases on record: 2 filed by the company and 3 filed against it. 1 is pending. Most are in the district courts.
Solace Biotech was incorporated on 22 July 2013, making it 13+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Solace Biotech by revenue are Lemford Biotech Private Limited, Manfriday Lifesciences Private Limited, Everwell Pharma Private Limited, Kaisha Lifesciences Private Limited, PRS Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations).
Satish Kumar ceased to be Director on 26 Dec 2022. Rohit Gupta was appointed as Director on 24 Dec 2022. Rohit Gupta ceased to be Director on 22 Feb 2020. Solace Biotech has 6 board changes on record in total.